Drug Price Trends for RIFABUTIN

Average Pharmacy Cost for RIFABUTIN

These are average pharmacy acquisition costs (net of discounts) from a US national survey

Drug Name	NDC	Price/Unit ($)	Unit	Date
RIFABUTIN 150 MG CAPSULE	59762-1350-01	9.95291	EACH	2025-05-21
RIFABUTIN 150 MG CAPSULE	70954-0041-10	9.95291	EACH	2025-05-21
RIFABUTIN 150 MG CAPSULE	59762-1350-01	9.90505	EACH	2025-04-23
RIFABUTIN 150 MG CAPSULE	70954-0041-10	9.90505	EACH	2025-04-23
RIFABUTIN 150 MG CAPSULE	59762-1350-01	9.64083	EACH	2025-03-19
RIFABUTIN 150 MG CAPSULE	70954-0041-10	9.64083	EACH	2025-03-19
RIFABUTIN 150 MG CAPSULE	59762-1350-01	9.38689	EACH	2025-02-19

Market Analysis and Price Projections for Rifabutin

Market Overview

Rifabutin, a member of the rifamycin derivatives drug class, is widely used for the treatment and prophylaxis of various mycobacterial infections, including those caused by Mycobacterium avium-intracellulare and tuberculosis, especially in HIV-positive patients.

Market Size and Growth

The global Rifabutin market has been experiencing significant growth, driven by several key factors. As of 2023, the Rifabutin market was valued at USD millions, and it is anticipated to expand substantially over the forecast period of 2024-2031. The market is expected to grow at a notable CAGR, reflecting the increasing demand for effective treatments against mycobacterial infections[2][4].

Drivers of Market Growth

Increasing Prevalence of Infectious Diseases

The rising incidence of tuberculosis (TB) and other mycobacterial infections, particularly in developing nations, is a major driver of the Rifabutin market. Public health initiatives aimed at controlling and eliminating TB also contribute to the increased demand for Rifabutin[3].

Multidrug-Resistant Infections

The growing problem of multidrug-resistant bacterial infections, where Rifabutin remains effective as part of combination therapies, further boosts the market. This includes the treatment of drug-resistant strains of TB[3].

Government and Global Health Initiatives

Efforts by public health organizations such as the World Health Organization (WHO) and the Centers for Disease Control and Prevention (CDC), along with national governments, to promote access to critical antibiotics like Rifabutin, support market growth. These initiatives often involve funding and programs to enhance the availability of these drugs[3].

Market Segmentation

By Type

The Rifabutin market is segmented based on the dosage of the drug, which includes 25 mg, 100 mg, and 150 mg capsules. The 150 mg dosage is one of the most commonly prescribed and thus holds a significant market share[2].

By Application

The market is also segmented by application, including pharmacy, hospital, clinic, and other settings. Hospitals and pharmacies are the primary distribution channels, with hospitals holding a larger share due to the need for controlled and monitored treatment of serious infections[2].

By Geography

Geographically, the Rifabutin market is divided into regions such as North America, Europe, Asia-Pacific, the Middle East and Africa, and Latin America. The Asia-Pacific region exhibits the largest market potential due to the high burden of infectious diseases and increasing healthcare initiatives in countries like India and China[3].

Price Projections

Current Pricing

As of the current market, the cost for Rifabutin 150 mg oral capsules can range from $996 to $1,200 for a supply of 100 capsules, depending on the pharmacy and any applicable discounts or insurance plans[5].

Future Pricing Trends

Given the anticipated growth in demand and the ongoing efforts to combat infectious diseases, the prices of Rifabutin are likely to remain stable or see moderate increases. However, pricing can be influenced by various factors such as production costs, regulatory changes, and market competition.

Competitive Landscape

The Rifabutin market is characterized by the presence of several key players, including RedHill Biopharma Ltd., Pfizer, Lupin, Olon, Janssen Pharma, and others. These companies are involved in various strategies such as product development, partnerships, and market expansion to maintain their market positions[2].

Challenges and Opportunities

Challenges

One of the significant challenges facing the Rifabutin market is the issue of drug resistance. As with other antibiotics, the misuse or overuse of Rifabutin can lead to the development of resistant strains, which could impact its effectiveness and market demand.

Opportunities

The increasing focus on public health initiatives and the growing need for effective treatments against mycobacterial infections present significant opportunities for the Rifabutin market. Innovations in drug delivery systems and personalized antibiotic therapies could also enhance market growth.

Key Takeaways

• Market Growth: The Rifabutin market is expected to grow significantly over the forecast period, driven by increasing demand and public health initiatives.
• Segmentation: The market is segmented by type, application, and geography, with the Asia-Pacific region showing the highest growth potential.
• Pricing: Current prices range from $996 to $1,200 for a 100-capsule supply, with future prices likely to remain stable or see moderate increases.
• Competitive Landscape: Several key players are active in the market, engaging in various strategies to maintain their positions.

FAQs

1. What is Rifabutin used for? Rifabutin is used for the treatment and prophylaxis of mycobacterial infections, including those caused by Mycobacterium avium-intracellulare and tuberculosis, especially in HIV-positive patients[5].

2. What are the key drivers of the Rifabutin market? The key drivers include the increasing prevalence of infectious diseases, the rise in multidrug-resistant infections, and government and global health initiatives to promote access to critical antibiotics[3].

3. How is the Rifabutin market segmented? The market is segmented by type (dosage), application (pharmacy, hospital, clinic), and geography (North America, Europe, Asia-Pacific, etc.)[2].

4. What is the current pricing for Rifabutin? The cost for Rifabutin 150 mg oral capsules can range from $996 to $1,200 for a supply of 100 capsules, depending on the pharmacy and any applicable discounts or insurance plans[5].

5. Who are the key players in the Rifabutin market? Key players include RedHill Biopharma Ltd., Pfizer, Lupin, Olon, Janssen Pharma, and others[2].

Sources

1. Market Research Intellect - Global Rifabutin Market Size, Scope And Forecast Report
2. Market Research Intellect - Global Rifabutin Market Size, Scope And Forecast Report
3. Verified Market Research - Rifampin Market Size, Share, Scope, Growth, Trends & Forecast
4. WICZ - Rifabutin Market 2024 Trend, Share, Sector Growth till 2032
5. Drugs.com - Rifabutin Prices, Coupons, Copay Cards & Patient Assistance

Last updated: 2024-12-31